Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 3.2 Amended and Restated Bylaws of Amgen, Inc.
- 10.93 Description of Amendment NO.2 to Amended and Restated Promotion Agreement
- 23.1 Consent of Ernst & Young LLP, Independment Auditors with Respect to Amgen Inc.
- 23.2 Consent of Pricewaterhousecoopers LLP with Respect to Tularik Inc
- 23.3 Consent of Ernst & Young LLP, Independent Auditors with Respect to Tularik Inc
- 23.6 Consent of Goldman, Sachs & Co.
- 99.1 Proxy Card of Tularik Inc.
AMGN similar filings
- 16 Nov 07 Registration of securities issued in business combination transactions
- 14 Mar 05 Registration of securities issued in business combination transactions
- 14 Mar 05 Registration of securities issued in business combination transactions
- 29 Jun 04 Registration of securities issued in business combination transactions (amended)
- 26 Apr 04 Registration of securities issued in business combination transactions
- 31 Jan 02 Registration of securities issued in business combination transactions
- 3 Nov 00 Registration of securities issued in business combination transactions
Filing view
External links
EXHIBIT 23.1
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-4, as amended) to be filed on June 29, 2004, and related Prospectus of Amgen Inc. for the registration of its common stock and to the incorporation by reference therein of our report dated January 21, 2004, with respect to the consolidated financial statements and schedule of Amgen Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2003, filed with the Securities and Exchange Commission.
/s/ ERNST & YOUNG LLP
Los Angeles, California
June 28, 2004